KLG Stock +78.58% In 3 Months Since We Picked KLG Stock +78.58% In 3 Months Since We Picked Unlock All Top Buy Picks
RSI low/high Values: [ 25 - 75 ]
* StockInvest.us uses dynamically calculated RSI max/min levels to determine when stock is oversold or overbought based on historical behavior.
AI Analysis of BIOCON.NS
Powered by GPT-4
Upgraded!
Stock Analysis
Risk Assessment
Trading Strategy

A very strong day for Biocon Limited stock price on Friday
(Updated on Apr 26, 2024)

Buy or Hold candidate since Apr 22, 2024 Gain 13.00% PDF

The Biocon Limited stock price gained 5.06% on the last trading day (Friday, 26th Apr 2024), rising from ₹291.65 to ₹306.40. It has now gained 5 days in a row. It will be exciting to see whether it manages to continue gaining or take a minor break for the next few days. During the last trading day the stock fluctuated 7.33% from a day low at ₹292.00 to a day high of ₹313.40. The price has risen in 7 of the last 10 days and is up by 12.94% over the past 2 weeks. Volume has increased on the last day along with the price, which is a positive technical sign, and, in total, 37 million more shares were traded than the day before. In total, 45 million shares were bought and sold for approximately ₹13.90 billion.

The stock has broken the wide and horizontal trend up. Breaks like this are often followed by swift and strong movements, and any correction down to the breakline at approximately. ₹295.49 is considered to be a "second chance" to hit a potential runner. It is, however, important that volume does follow the price as false breaks may appear and it may move back into the horizontal trend. Based on the rectangle-formation theory the stock is predicted to reach ₹346.65 sometime during the next 3 months.

Ready to grow your portfolio? Here's your beginner's guide to opening a free brokerage account.

BIOCON.NS Signals & Forecast

The Biocon Limited stock holds buy signals from both short and long-term Moving Averages giving a positive forecast for the stock. Also, there is a general buy signal from the relation between the two signals where the short-term average is above the long-term average. On corrections down, there will be some support from the lines at ₹281.11 and ₹268.56. A breakdown below any of these levels will issue sell signals. A buy signal was issued from a pivot bottom point on Tuesday, March 19, 2024, and so far it has risen 24.68%. Further rise is indicated until a new top pivot has been found. Furthermore, there is a buy signal from the 3 month Moving Average Convergence Divergence (MACD). Volume is rising along with the price. This is considered to be a good technical signal. The stock had a Golden Star Signal on Friday, March 01, 2024 in the short-term chart.

Golden Star Signal is when the short-term moving average, the long-term moving average, and price line meet in a special combination. This combination is very rare and often followed by long and strong gains for the stock in question.

Buy
Special Signal Notification

Golden Star

The stock had a Golden Star Signal on Friday, March 01, 2024 in the short-term chart.

Golden Star Signal is when the short-term moving average, the long-term moving average, and price line meet in a special combination. This combination is very rare and often followed by long and strong gains for the stock in question.

Support, Risk & Stop-loss for Biocon Limited stock

Biocon Limited finds support from accumulated volume at ₹298.55 and this level may hold a buying opportunity as an upwards reaction can be expected when the support is being tested.

This stock has average movements during the day and with good trading volume, the risk is considered to be medium. During the last day, the stock moved ₹21.40 between high and low, or 7.33%. For the last week, the stock has had daily average volatility of 4.34%.

Our recommended stop-loss: ₹295.43 (-3.58%) (This stock has medium daily movements and this gives medium risk. There is a buy signal from a pivot bottom found 25 days ago.)

Trading Expectations (BIOCON.NS) For The Upcoming Trading Day Of Monday 29th

For the upcoming trading day on Monday, 29th we expect Biocon Limited to open at ₹303.93, and during the day (based on 14 day Average True Range), to move between ₹296.10 and ₹316.70, which gives a possible trading interval of +/-₹10.30 (+/-3.36%) up or down from last closing price. If Biocon Limited takes out the full calculated possible swing range there will be an estimated 6.72% move between the lowest and the highest trading price during the day.

With no resistance above and support from accumulated volume @ ₹298.55, some ₹7.85 (2.56%) from the current price of ₹306.40, our system finds the risk reward attractive.

Is Biocon Limited stock A Buy?

Biocon Limited holds several positive signals, but we still don't find these to be enough for a buy candidate. At the current level, it should be considered as a hold candidate (hold or accumulate) in this position whilst awaiting further development. Due to some small weaknesses in the technical picture we have downgraded our analysis conclusion for this stock since the last evaluation from a Buy to a Hold/Accumulate candidate.

Current score: 0.000 Hold/Accumulate Downgraded

Zero in score indicates that our system is expecting high volatility and risk for the following trading day. Given the latest developments, we cannot determine the next direction as it may go both ways.

Predicted Opening Price for Biocon Limited of Monday, April 29, 2024

Fair opening price April 29, 2024 Current price
₹303.93 ( 0.81%) ₹306.40

The predicted opening price is based on yesterday's movements between high, low, and closing price.

Trading levels for BIOCON.NS

Fibonacci Support & Resistance Levels

Level Price
Resistance R3 325.33 6.18 %
R2 317.16 3.51 %
R1 312.11 1.86 %
Current price: 306.40
Support S1 295.76 -3.47 %
S2 290.71 -5.12 %
S3 282.53 -7.79 %

Accumulated Volume Support & Resistance Levels

Level Price
Resistance R3 0 .
R2 0 .
R1 0 .
Current price 306.40
Support S1 298.55 -2.56%
S2 291.05 -5.01%
S3 289.60 -5.48%

BIOCON Dividend Payout History


# Declaration Date Ex-Date Pay Date Amount Yield
1 Jul 07, 2023 Jul 07, 2023 Jul 07, 2023 ₹1.50 0.591%
2 Jul 06, 2023 Jul 06, 2023 Jul 06, 2023 ₹1.50 0.578%
3 Jun 30, 2022 Jun 30, 2022 Jun 30, 2022 ₹0.500 0.162%
4 Apr 25, 2019 Jul 18, 2019 Aug 02, 2019 ₹0.500 0.216%
5 Apr 26, 2018 Jul 19, 2018 Aug 26, 2018 ₹0.500 0.165%

FAQ

What is the symbol for Biocon Limited Stock and on which exchange is it traded?
The symbol for Biocon Limited is BIOCON.NS and it is traded on the NSE (National Stock Exchange of India).

Should I buy or sell Biocon Limited Stock?
Biocon Limited holds several positive signals, but we still don't find these to be enough for a buy candidate. At the current level, it should be considered as a hold candidate (hold or accumulate) in this position whilst awaiting further development. Due to some small weaknesses in the technical picture we have downgraded our analysis conclusion for this stock since the last evaluation from a Buy to a Hold/Accumulate candidate.

How to buy Biocon Limited Stock?
Biocon Limited Stock can be purchased through just about any brokerage firm, including online brokerage services.
Click here for our free guide on how to buy Biocon Limited Stock.

What's the current price of Biocon Limited Stock?
As of the end of day on the Apr 26, 2024, the price of an Biocon Limited (BIOCON.NS) share was ₹306.40.

What is the 52-week high and low for Biocon Limited Stock?
The 52-week high for Biocon Limited Stock is ₹313.40 and the 52-week low is ₹217.50.

What is the market capitalization of Biocon Limited Stock?
As of the Apr 26, 2024, the market capitalization of Biocon Limited is 367.864B.

When is the next earnings date for Biocon Limited?
The upcoming earnings date for Biocon Limited is May 16, 2024.
Click to get the best stock tips daily for free!

About Biocon Limited

Biocon Limited Biocon Limited, a biopharmaceutical company, manufactures pharmaceuticals, and medicinal chemical and botanical products. The company operates through Generics, Novel Biologics, Biosimilars, and Research Services segments. It focuses in the areas of diabetes, oncology, immunology, ophthalmology, and bone health diseases. In addition, It is involved in the integrated discovery, development, and manufacturing services for small and large molecules.... BIOCON.NS Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT